Killing activity of human umbilical cord blood-derived TCRValpha24+ NKT cells against normal and malignant hematological cells in vitro: A comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells

Cancer Immunology, Immunotherapy

Volumn 51, Issue 1, 2002, Pages 1-8

  Hagihara, Masao ^a   Gansuvd, Balgansuren ^a   Ueda, Yoko ^a   Tsuchiya, Takahide ^a   Masui, Aya ^a   Tazume, Kei ^a   Inoue, Hiroyasu ^a   Kato, Shunichi ^a   Hotta, Tomomitsu ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Cytotoxicity; Dendritic cells; Hematological malignancy; Umbilical cord blood; V 24+ NKT cells

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3; OKT 3; STEM CELL FACTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOMA CELL; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD1; ANTIGENS, NEOPLASM; AUTOIMMUNITY; BLOOD CELLS; CELL LINE, TRANSFORMED; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MUROMONAB-CD3; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0036178623     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-001-0246-2     Document Type: Article

References (39)

1. - T-cell deficiency and IDDM in NOD/Lt mice
2. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells
3. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
4. Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d
5. Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR
6. + NKT lymphocytes are activated memory cells
7. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
8. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis
9. Cord blood stem cell transplantation
10. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
11. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: Relevance to umbilical cord blood transplantation
12. Umbilical cord blood stem cell transplantation and banking
13. + NK cells in vitro
14. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides
15. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand
16. Antitumor cytotoxicity mediated by ligand-activated human Valpha24 NKT cells
17. Non-canonical Valpha24JalphaQ T cells with conservative alpha chain CDR3 region amino acid substitutions are restricted by CD1d
18. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
19. A novel immunomodulator, and its antitumor activities
20. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
21. Surface receptors delivering opposite signals regulate the function of human NK cells
22. High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: Evaluation of cytolytic activity and IL-2 production
23. + natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells
24. + natural killer T-cell cytotoxic activity: An important immune regulatory function
25. Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24-TCR-mediated manner
26. + T cells in vitro
27. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
28. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia
29. - alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain
30. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation
31. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
32. Selective reduction of T cells bearing invariant V alpha 24 J alpha Q antigen receptor in patients with systemic sclerosis
33. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood
34. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen
35. + NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells
36. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells
37. Human natural killer T cells acquire a memory-activated phenotype before birth
38. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through upregulation of the interleukin-12 receptor and STAT4
39. Targeting of human dendritic cells by autologous NK cells